Keywords: files, eu, approval, glaucoma, dual-therapy, pharmacia, upjohn

P&U files for EU approval of glaucoma dual-therapy

Article | 24 February 2000

Pharmacia & Upjohn has filed for Swedish approval of a fixedcombination of Xalatan (latanoprost ophthalmic solution) plus the beta blocker timolol, ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Pharmacia

Go to company listing

Related Drugs

Latanoprost Ophthalmic

Xalatan

Blocadren

Timolol

Go to drug listing